{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T01:12:53Z","timestamp":1782436373535,"version":"3.54.5"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:00:00Z","timestamp":1710806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>This study focuses on understanding pharmacovigilance knowledge, attitudes, and practices (KAP) in Yunnan Province, employing Structural Equation Modeling (SEM) and network analysis. It aims to evaluate the interplay of these factors among healthcare personnel and the public, assessing the impact of demographic characteristics to inform policy and educational initiatives.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A cross-sectional survey was conducted in Yunnan, targeting healthcare personnel and the public. Data collection was through questionnaires, with subsequent analysis involving correlation matrices, network visualization, and SEM. The data analysis utilized SPSS 27.0, AMOS 26.0, and Gephi software for network analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>This study evaluated pharmacovigilance KAP among 209 public participants and 823 healthcare personnel, uncovering significant differences. Public respondents scored averages of 4.62\u2009\u00b1\u20092.70 in knowledge, 31.99\u2009\u00b1\u20094.72 in attitudes, and 12.07\u2009\u00b1\u20094.96 in practices, while healthcare personnel scored 4.38\u2009\u00b1\u20093.06, 27.95\u2009\u00b1\u20093.34, and 7.75\u2009\u00b1\u20092.77, respectively. Statistically significant correlations across KAP elements were observed in both groups, highlighting the interconnectedness of these factors. Demographic influences were more pronounced among healthcare personnel, emphasizing the role of professional background in pharmacovigilance competency. Network analysis identified knowledge as a key influencer within the pharmacovigilance KAP network, suggesting targeted education as a vital strategy for enhancing pharmacovigilance engagement.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The research reveals a less-than-ideal state of pharmacovigilance KAP among both healthcare personnel and the public in Yunnan, with significant differences between the two groups. SEM and network analysis confirmed a strong positive link among KAP components, moderated by demographics like age, occupation, and education level. These insights emphasize the need to enhance pharmacovigilance education and awareness, thereby promoting safer drug use.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2024.1358117","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T04:49:56Z","timestamp":1710823796000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Cross-sectional study of pharmacovigilance knowledge, attitudes, and practices based on structural equation modeling and network analysis: a case study of healthcare personnel and the public in Yunnan Province"],"prefix":"10.3389","volume":"12","author":[{"given":"Dan","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,3,19]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1007\/s11096-018-0657-1","article-title":"An historical overview of Pharmacovigilance","volume":"40","author":"Fornasier","year":"2018","journal-title":"Int J Clin Pharmacol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s11096-018-0693-x","article-title":"Pharmacovigilance in China: Development and challenges","volume":"40","author":"Zhao","year":"2018","journal-title":"Int J Clin Pharmacol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1111\/bcp.14042","article-title":"Measuring the impact of pharmacovigilance activities, challenging but important","volume":"85","author":"Van Hunsel","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s43441-022-00415-y","article-title":"A Systematic Review of Pharmacovigilance Systems in Developing Countries Using the WHO Pharmacovigilance Indicators","volume":"56","author":"Garashi","year":"2022","journal-title":"Ther Innov Regul Sci"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s40264-014-0222-3","article-title":"Pharmacovigilance in China: Current Situation, Successes","volume":"37","author":"Zhang","year":"2014","journal-title":"Challenges. Drug Saf"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s40290-015-0133-3","article-title":"Pharmacovigilance in Nigeria: An Overview","volume":"30","author":"Olowofela","year":"2016","journal-title":"Pharm Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40545-016-0053-y","article-title":"Governance and pharmacovigilance in Brazil: a scoping review","volume":"9","author":"Moscou","year":"2016","journal-title":"J of Pharm Policy and Pract"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"170","DOI":"10.4103\/picr.PICR_89_17","article-title":"Comparative evaluation of pharmacovigilance regulation of the United States, United Kingdom, Canada, India and the need for global harmonized practices","volume":"9","author":"Hans","year":"2018","journal-title":"Perspect Clin Res"},{"key":"ref9","volume-title":"Principles and Practice of Structural Equation Modeling","author":"Kline","year":"2015"},{"key":"ref10","volume-title":"Confirmatory Factor Analysis for Applied Research","author":"Brown","year":"2015"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s12913-022-07720-0","article-title":"A cross-sectional study: comparison of public perceptions of adverse drug reaction reporting and monitoring in eastern and western China","volume":"22","author":"Wang","year":"2022","journal-title":"BMC Health Serv Res"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"780","DOI":"10.21873\/invivo.12765","article-title":"A Comparative Safety Analysis of Medicines Based on the UK Pharmacovigilance and General Practice Prescribing Data in England","volume":"36","author":"Mokbel","year":"2022","journal-title":"In Vivo"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1016\/j.sapharm.2021.05.010","article-title":"Factors influencing patient intention to report adverse drug reaction to community pharmacists: A structural equation modeling approach","volume":"18","author":"Assanee","year":"2022","journal-title":"Res Social Adm Pharm"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/schbul\/sbac131","article-title":"Longitudinal Network Analysis Reveals Interactive Change of Schizophrenia Symptoms During Acute Antipsychotic Treatment","volume":"49","author":"Sun","year":"2023","journal-title":"Schizophr Bull"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"417","DOI":"10.13898\/j.cnki.issn.1000-2200.2021.03.037","article-title":"The current situation of \u201cknowledge, belief, and practice\u201d of breast self-examination among female college students in Anhui Province and structural equation model analysis [J]","volume":"46","author":"Hua","year":"2021","journal-title":"Journal of Bengbu Medical Coll."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"791","DOI":"10.16168\/j.cnki.issn.1002-9982.2022.09.005","article-title":"Research on knowledge, attitude, and practice of HPV vaccine among women of appropriate age in Guiyang based on structural equation model [J]","volume":"38","author":"Li","year":"2022","journal-title":"China Health Edu."},{"key":"ref17","first-page":"826","article-title":"A KAP model for malaria prevention and control based on multiple sets of structural equation models [J]. China","volume":"36","author":"He","year":"2020","journal-title":"Public Health."},{"key":"ref18","first-page":"195","article-title":"Empirical study on the relationship between knowledge, attitude, and practice of hypertensive patients based on structural equation model [J]","volume":"42","author":"Zeng","year":"2017","journal-title":"Journal of Central South University (Medical Edition)"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1186\/s12913-019-4775-9","article-title":"Awareness, knowledge, attitude and practice of adverse drug reaction reporting among health workers and patients in selected primary healthcare centres in Ibadan, southwestern Nigeria","volume":"19","author":"Adisa","year":"2019","journal-title":"BMC Health Serv Res"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/pharmacy7010019","article-title":"General Public Views, Attitudes, and Experiences toward Drug Safety in Dubai, United Arab Emirates: A Qualitative Approach","volume":"7","author":"Alkhalidi","year":"2019","journal-title":"Pharmacy (Basel)."},{"key":"ref21","first-page":"407","article-title":"Public reporting model for adverse drug reactions in China","volume":"14","author":"Wu","year":"2017","journal-title":"Chinese Journal of Pharmacovigilance"},{"key":"ref22","first-page":"192","article-title":"Current Situation and Countermeasures of Public Reports about Adverse Drug Reactions in China","volume":"16","author":"Pan","year":"2019","journal-title":"Chinese Journal of Rational Drug Use"},{"key":"ref23","first-page":"1","article-title":"Report of a WHO meeting","volume":"498","year":"1972","journal-title":"World Health Organ Tech Rep Ser"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s11096-018-0693-x","article-title":"Pharmacovigilance in China: development and challenges","volume":"40","author":"Zhao","year":"2018","journal-title":"Int J Clin Pharm."},{"key":"ref25","unstructured":"AdministrationNational Medical Products\n          NMPAAnnouncement on the Annual Report for National ADR Monitoring (2018)2019"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/03007995.2020.1846171","article-title":"Knowledge, attitude, and practice regarding pharmacovigilance among the general public in Western China: a cross-sectional study","volume":"37","author":"Chen","year":"2021","journal-title":"Curr Med Res Opin."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.drugalcdep.2016.02.005","article-title":"Network analysis of substance abuse and dependence symptoms","volume":"161","author":"Rhemtulla","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"ref28","first-page":"966","article-title":"Analysis of the current situation of knowledge, belief, and practice in safe medication among women in China using a multi group structural equation model","volume":"57","author":"Li","year":"2022","journal-title":"Chinese Journal of Pharmacy"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2024.1358117\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T04:50:11Z","timestamp":1710823811000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2024.1358117\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,19]]},"references-count":28,"alternative-id":["10.3389\/fpubh.2024.1358117"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2024.1358117","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,19]]},"article-number":"1358117"}}